Literature DB >> 28263088

Active learning for computational chemogenomics.

Daniel Reker1,2, Petra Schneider1,3, Gisbert Schneider1, J B Brown4.   

Abstract

AIM: Computational chemogenomics models the compound-protein interaction space, typically for drug discovery, where existing methods predominantly either incorporate increasing numbers of bioactivity samples or focus on specific subfamilies of proteins and ligands. As an alternative to modeling entire large datasets at once, active learning adaptively incorporates a minimum of informative examples for modeling, yielding compact but high quality models. Results/methodology: We assessed active learning for protein/target family-wide chemogenomic modeling by replicate experiment. Results demonstrate that small yet highly predictive models can be extracted from only 10-25% of large bioactivity datasets, irrespective of molecule descriptors used.
CONCLUSION: Chemogenomic active learning identifies small subsets of ligand-target interactions in a large screening database that lead to knowledge discovery and highly predictive models.

Keywords:  chemogenomics; computational chemistry and modeling; virtual screening

Mesh:

Substances:

Year:  2017        PMID: 28263088     DOI: 10.4155/fmc-2016-0197

Source DB:  PubMed          Journal:  Future Med Chem        ISSN: 1756-8919            Impact factor:   3.808


  17 in total

1.  Validation strategies for target prediction methods.

Authors:  Neann Mathai; Ya Chen; Johannes Kirchmair
Journal:  Brief Bioinform       Date:  2020-05-21       Impact factor: 11.622

2.  Active learning effectively identifies a minimal set of maximally informative and asymptotically performant cytotoxic structure-activity patterns in NCI-60 cell lines.

Authors:  Takumi Nakano; Shunichi Takeda; J B Brown
Journal:  RSC Med Chem       Date:  2020-07-20

Review 3.  Automating drug discovery.

Authors:  Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2017-12-15       Impact factor: 84.694

4.  CATMoS: Collaborative Acute Toxicity Modeling Suite.

Authors:  Kamel Mansouri; Agnes L Karmaus; Jeremy Fitzpatrick; Grace Patlewicz; Prachi Pradeep; Domenico Alberga; Nathalie Alepee; Timothy E H Allen; Dave Allen; Vinicius M Alves; Carolina H Andrade; Tyler R Auernhammer; Davide Ballabio; Shannon Bell; Emilio Benfenati; Sudin Bhattacharya; Joyce V Bastos; Stephen Boyd; J B Brown; Stephen J Capuzzi; Yaroslav Chushak; Heather Ciallella; Alex M Clark; Viviana Consonni; Pankaj R Daga; Sean Ekins; Sherif Farag; Maxim Fedorov; Denis Fourches; Domenico Gadaleta; Feng Gao; Jeffery M Gearhart; Garett Goh; Jonathan M Goodman; Francesca Grisoni; Christopher M Grulke; Thomas Hartung; Matthew Hirn; Pavel Karpov; Alexandru Korotcov; Giovanna J Lavado; Michael Lawless; Xinhao Li; Thomas Luechtefeld; Filippo Lunghini; Giuseppe F Mangiatordi; Gilles Marcou; Dan Marsh; Todd Martin; Andrea Mauri; Eugene N Muratov; Glenn J Myatt; Dac-Trung Nguyen; Orazio Nicolotti; Reine Note; Paritosh Pande; Amanda K Parks; Tyler Peryea; Ahsan H Polash; Robert Rallo; Alessandra Roncaglioni; Craig Rowlands; Patricia Ruiz; Daniel P Russo; Ahmed Sayed; Risa Sayre; Timothy Sheils; Charles Siegel; Arthur C Silva; Anton Simeonov; Sergey Sosnin; Noel Southall; Judy Strickland; Yun Tang; Brian Teppen; Igor V Tetko; Dennis Thomas; Valery Tkachenko; Roberto Todeschini; Cosimo Toma; Ignacio Tripodi; Daniela Trisciuzzi; Alexander Tropsha; Alexandre Varnek; Kristijan Vukovic; Zhongyu Wang; Liguo Wang; Katrina M Waters; Andrew J Wedlake; Sanjeeva J Wijeyesakere; Dan Wilson; Zijun Xiao; Hongbin Yang; Gergely Zahoranszky-Kohalmi; Alexey V Zakharov; Fagen F Zhang; Zhen Zhang; Tongan Zhao; Hao Zhu; Kimberley M Zorn; Warren Casey; Nicole C Kleinstreuer
Journal:  Environ Health Perspect       Date:  2021-04-30       Impact factor: 9.031

Review 5.  Rethinking drug design in the artificial intelligence era.

Authors:  Petra Schneider; W Patrick Walters; Alleyn T Plowright; Norman Sieroka; Jennifer Listgarten; Robert A Goodnow; Jasmin Fisher; Johanna M Jansen; José S Duca; Thomas S Rush; Matthias Zentgraf; John Edward Hill; Elizabeth Krutoholow; Matthias Kohler; Jeff Blaney; Kimito Funatsu; Chris Luebkemann; Gisbert Schneider
Journal:  Nat Rev Drug Discov       Date:  2019-12-04       Impact factor: 84.694

6.  Assigning confidence to molecular property prediction.

Authors:  AkshatKumar Nigam; Robert Pollice; Matthew F D Hurley; Riley J Hickman; Matteo Aldeghi; Naruki Yoshikawa; Seyone Chithrananda; Vincent A Voelz; Alán Aspuru-Guzik
Journal:  Expert Opin Drug Discov       Date:  2021-06-15       Impact factor: 7.050

Review 7.  Identification of neoantigens for individualized therapeutic cancer vaccines.

Authors:  Franziska Lang; Barbara Schrörs; Martin Löwer; Özlem Türeci; Ugur Sahin
Journal:  Nat Rev Drug Discov       Date:  2022-02-01       Impact factor: 112.288

8.  Classifiers and their Metrics Quantified.

Authors:  J B Brown
Journal:  Mol Inform       Date:  2018-01-23       Impact factor: 3.353

9.  Similarity-Based Methods and Machine Learning Approaches for Target Prediction in Early Drug Discovery: Performance and Scope.

Authors:  Neann Mathai; Johannes Kirchmair
Journal:  Int J Mol Sci       Date:  2020-05-19       Impact factor: 5.923

10.  Prediction of Compound Profiling Matrices, Part II: Relative Performance of Multitask Deep Learning and Random Forest Classification on the Basis of Varying Amounts of Training Data.

Authors:  Raquel Rodríguez-Pérez; Jürgen Bajorath
Journal:  ACS Omega       Date:  2018-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.